Cancers (Oct 2021)

Lymphoma-Associated Biomarkers Are Increased in Current Smokers in Twin Pairs Discordant for Smoking

  • Jun Wang,
  • David V. Conti,
  • Marta Epeldegui,
  • Miina Ollikainen,
  • Rachel F. Tyndale,
  • Amie Eunah Hwang,
  • Larry Magpantay,
  • Thomas McCulloch Mack,
  • Otoniel Martinez-Maza,
  • Jaakko Kaprio,
  • Wendy Cozen

DOI
https://doi.org/10.3390/cancers13215395
Journal volume & issue
Vol. 13, no. 21
p. 5395

Abstract

Read online

Smoking is associated with a moderate increased risk of Hodgkin and follicular lymphoma. To understand why, we examined lymphoma-related biomarker levels among 134 smoking and non-smoking twins (67 pairs) ascertained from the Finnish Twin Cohort. Previously collected frozen serum samples were tested for cotinine to validate self-reported smoking history. In total, 27 immune biomarkers were assayed using the Luminex Multiplex platform (R & D Systems). Current and non-current smokers were defined by a serum cotinine concentration of >3.08 ng/mL and ≤3.08 ng/mL, respectively. Associations between biomarkers and smoking were assessed using linear mixed models to estimate beta coefficients and standard errors, adjusting for age, sex and twin pair as a random effect. There were 55 never smokers, 43 current smokers and 36 former smokers. CCL17/TARC, sgp130, haptoglobin, B-cell activating factor (BAFF) and monocyte chemoattractant protein-1 (MCP1) were significantly (p Ptrend Ptrend = 0.0001). Immune biomarker levels were similar in former and never smokers. Current smoking is associated with increased levels of lymphoma-associated biomarkers, suggesting a possible mechanism for the link between smoking and risk of these two B-cell lymphomas.

Keywords